Answers are grounded in this paper and cite their sources.
Case report reveals isolated pulmonary hypertension in a toddler with cobalamin C defect, highlighting metabolic errors in the differential diagnosis of pediatric vascular disease.
Cobalamin C (cblC) defect is the most common inborn error of vitamin B12 metabolism. Clinical features vary as does the severity of the disease. In most cases, the clinical symptoms of cblC defect tend to appear during infancy or early childhood as a multisystem disease with severe neurologic, ocular, hematologic, renal, and gastrointestinal signs. The neurologic findings are common and include hypotonia, developmental delay, microcephaly, seizures hydrocephalus, and brain MRI abnormalities. We report a case of a young boy with cblC defect, who did not undergo newborn screening, presenting at the age of 2 years with isolated pulmonary hypertension as the leading symptom. This novel way of presentation of cblC defect enlarges the spectrum of inherited diseases that must be considered in the differential diagnosis of pulmonary hypertension.
No takes yet. Share an insight, caveat, or question.
Iodice et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: